Consolidated Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Consolidated Statements Of Operations
Revenue	$ 19,922
Operating expenses
Research and development expense	(727,091)	(1,645,939)
Selling, general and administrative expense	(2,764,836)	(2,548,007)
Total operating expenses	(3,491,927)	(4,193,946)
Loss from operations	(3,472,005)	(4,193,946)
Other Income from Change in Fair Value of Warrants	1,202,489	3,716,812
Loss on issuance of warrants	(621,983)	(4,983)
Interest income	3,466	3,455
Other income		51,261
Gain on settlement of obligations		(845,000)
(Loss) income from continuing operations before taxes	(2,888,033)	417,599
Income tax expense		(14,485)
(Loss) income from continuing operations	(2,888,033)	403,114
Discontinued operations
Loss from discontinued operations	(968,991)	(383,529)
Income tax expense
Loss from discontinued operations	(968,991)	(383,529)
Net (loss) income	$ (3,857,024)	$ 19,585
Net (loss) income per share, basic
Continuing operations	$ (10.56)	$ 3.07
Discontinued operations	$ (3.54)	$ (2.92)
Net (loss) income per share	$ (14.10)	$ 0.15
Net loss per share, diluted
Continuing operations	$ (10.56)	$ (2.37)
Discontinued operations	$ (3.54)	$ (2.77)
Net loss per share	$ (14.10)	$ (5.14)
Weighted average shares outstanding, basic	273,567	131,285
Weighted average shares outstanding, diluted	273,567	138,346